STOCK TITAN

IPSEN: Disclosure Transaction in Own Shares Between 13/06/2022 and 17/06/2022

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

PARIS--(BUSINESS WIRE)-- Regulatory News:

IPSEN:

Aggregated presentation by day and market

Issuer name Issuer identification code Transaction date Identification code of the financial instrument Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform
IPSEN 549300M6SGDPB4Z94P11 13/06/2022 FR0010259150

7,500

86.2925

XPAR
IPSEN 549300M6SGDPB4Z94P11 14/06/2022 FR0010259150

5,433

84.7013

XPAR
IPSEN 549300M6SGDPB4Z94P11 15/06/2022 FR0010259150

2,500

84.1820

XPAR
IPSEN 549300M6SGDPB4Z94P11 16/06/2022 FR0010259150

7,000

81.6339

XPAR
IPSEN 549300M6SGDPB4Z94P11 17/06/2022 FR0010259150

4,957

81.2863

XPAR
TOTAL

27,390

83.6876

 

Craig Marks

Vice-President Investor Relations

Tel.: +44 (0) 7584 349 193

E-mail: craig.marks@ipsen.com

Fabien Puibarreau

Head of Company Law and Securities Law

Tel.: +33 (0)1 58 33 58 86

E-mail: fabien.puibarreau@ipsen.com

Source: IPSEN

Ipsen Sa

OTC:IPSEY

IPSEY Rankings

IPSEY Latest News

IPSEY Stock Data

10.09B
330.84M
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
France
Boulogne-Billancourt